Can international students get ADHD medication in Canada?

A prescriber's decision depends on clinical assessment, not immigration status

Once a licensed nurse practitioner or physician confirms an ADHD diagnosis using DSM-5-TR criteria and CADDRA-aligned practice, whether or not to prescribe medication is based on clinical judgment about your symptoms, health history, and preferences, the same as it would be for any other patient. A valid study permit does not create any additional barrier to this process.

Medication is only discussed after a diagnostic assessment, not before

Finding Focus's adult assessment is a one-time $399 fee for a video visit of up to 75 minutes with a licensed nurse practitioner or clinician working with Finding Focus. Results and a treatment plan are often available within hours, though this depends on case complexity and is not guaranteed. If medication is part of the plan, that conversation covers stimulant medications and non-stimulant options as a balanced discussion of benefits and risks; the clinician decides what, if anything, is appropriate for you.

1. Complete the free screener at get-started, a screening tool rather than a diagnosis.
2. Book and attend the video assessment from your current province of study.
3. Receive results: the clinician may confirm ADHD, rule it out, or refer you further.
4. If appropriate, discuss medication options and next steps for ongoing care.

Medication cost is usually a university health insurance question, not a provincial one

Many international students are enrolled in a mandatory university health insurance plan, such as UHIP in Ontario or an equivalent elsewhere, rather than the provincial public plan, since provincial coverage for newcomers can involve a waiting period. Whether your specific medication is reimbursed depends entirely on your plan's own formulary and rules, not on your student status generally, so check your plan's documents directly rather than assuming coverage either way.

Not every medication and formulation is guaranteed to be in steady supply

Health Canada's Drug Product Database lists which products are authorized for sale in Canada, and Health Canada's drug shortages hub, along with its consumer-facing supply notices, tracks active and resolved shortage events. A prescriber will discuss what is currently and reliably available when recommending a specific option, and can adjust the plan if a particular product becomes harder to access.

If a change of province happens during your studies, note that a nurse practitioner's authority to prescribe is tied to the province where they are licensed and where you are physically located, so continuity of prescribing can be affected by a move between provinces. This is worth raising directly with your clinician if your study plans involve relocating.

Ongoing prescribing continues through a separate, optional follow-up plan

After the initial assessment, follow-up care is available through an optional $29.99 per month membership or a $74.99 per-check-in fee without a membership. A standard diagnosis letter ($49) or a healthcare-provider report ($99) is available if you need documentation for a school accessibility office, an employer, or an insurer.

If you were already diagnosed with ADHD and taking medication in your home country before starting your studies in Canada, mention this during your assessment. Bringing your prior diagnosis documentation and medication history can make the Canadian assessment more efficient, and you may qualify for 50 percent off the initial consultation if already diagnosed elsewhere, conditions apply. Your Canadian clinician will still independently confirm the diagnosis and decide on an appropriate treatment plan rather than automatically continuing a foreign prescription unchanged.